Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.
about
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of tiotropi ...... da, Spain, Sweden, and the UK.
@en
Cost-effectiveness of tiotropi ...... da, Spain, Sweden, and the UK.
@nl
type
label
Cost-effectiveness of tiotropi ...... da, Spain, Sweden, and the UK.
@en
Cost-effectiveness of tiotropi ...... da, Spain, Sweden, and the UK.
@nl
prefLabel
Cost-effectiveness of tiotropi ...... da, Spain, Sweden, and the UK.
@en
Cost-effectiveness of tiotropi ...... da, Spain, Sweden, and the UK.
@nl
P2093
P2860
P921
P356
P1476
Cost-effectiveness of tiotropi ...... da, Spain, Sweden, and the UK.
@en
P2093
Andrew Ternouth
Carlos Crespo
Faraz Afzal
Fredrik Borgström
Jason Flavin
Maria Eugenia Ojanguren
Mike Baldwin
Oskar Eklund
P2860
P304
P356
10.2147/CEOR.S105579
P407
P577
2016-06-11T00:00:00Z